2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 (188-192)
АУТОР(И) / AUTHOR(S): Neda Milosavljević, Marija Živković Radojević, Darko Stojanović, Marko Spasić
Е-АДРЕСА / E-MAIL: neda.milosavljevic@yahoo.com
DOI: 10.46793/ICCBI23.188M
САЖЕТАК / ABSTRACT:
Pauses in radiotherapy treatment is a significant problem that affects overall treatment time – a predictor of tumor proliferation and definitive patient outcome and demands a decision-making tool for optimizing doses between healthy tissue and target volumes.
During prolonged radiotherapy interruptions, linear-quadratic model showed inadequacy in predicting tumor proliferation. We have developed a radiobiology algorithm applied for dose compensating, providing multiple options for dose compensating due to prolonged pauses. Based on linear-quadratic (LQ) model providing, in specific cases, orientational values for tumors and organs at risk (OAR), we developed a radiobiology calculator that can be used in dose compensation, giving more than one option in correcting biological effective dose (BED) due to prolonged pauses. Generic OAR offers the opportunity to individualize α/β ratio for any organ at risk or tumor. Seven cancer patients who experienced radiotherapy treatment delays, for more than two weeks, are included in this research.
The developed algorithm offers the radiation oncologist optimal modality choice and can be a helpful tool for overcoming long delays, except for patients whose treatment interruptions occur at the end of radiation treatment and for patients with fast proliferating tumors. During this course of treatment, none of the included patients manifested severe acute radiotherapy adverse events.
The dose compensating algorithm can be a useful tool for dose calculations with optimal healthy tissue sparing, but large prospective studies are necessary to confirm the benefit.
КЉУЧНЕ РЕЧИ / KEYWORDS:
radiotherapy, dose compensation, algorithm
ЛИТЕРАТУРА / REFERENCES:
- Yang Y, Cameron J, Humphris G. The relationship between cancer patient’s fear of recurrence and radiotherapy: a systematic review and meta-analysis. Psychooncology 2017;26(6):738-46.
- Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians 70 7–30.
- Fietkau R, Rödel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens J, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R; German Rectal Cancer Study Group. Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1008-19.
- Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23(2):457-67.
- Оsei E, Francis R, Mohamed A, Sheraz L, Soltani-Mayvan F. Impact of COVID-19 pandemic on the oncologic care continuum: urgent need to restore patients care to pre-COVID-19 era. J Radiother Pract. 2021 Apr 19:1–11.
- Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31(5):1341-6.
National Cancer Institute, National Institutes of Health USD. U.S. Department of health and human services. Common Terminology Criteria for Adverse Events (CTCAE). U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 Published: November 27, 2017. - Royal College of Radiologists. The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions. 2008. (Third edition).
- Putora PM, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol. 2012 Dec 8;7:208.
- Abolfath R, Khalili M, Senejani AG, Kodery B, Ivker R. The Dependence of Compensation Dose on Systematic and Random Interruption Treatment Time in Radiation Therapy. Onco. 2022; 2(3):264-281.